SMTL ID : 4hf4.1 (1 other biounit)

Crystal Structure of PDE10A with a biaryl ether inhibitor (1-(1-(3-(4-(benzo[d]thiazol-2-ylamino)phenoxy)pyrazin-2-yl)piperidin-4-yl)ethanol)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-trimer

Ligands

6 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: H.78, H.112, D.113, D.223 Ligands: ZN.2 6 PLIP interactions: 4 interactions with chain A, 2 Ligand-Water interactions Metal complexes: A:H.78, A:H.112, A:D.113, A:D.223, H2O.3, H2O.120 ZN.2: 2 residues within 4Å: Chain A: D.113 Ligands: ZN.1 6 PLIP interactions: 1 interactions with chain A, 5 Ligand-Water interactions Metal complexes: A:D.113, H2O.7, H2O.66, H2O.85, H2O.90, H2O.120 ZN.13: 5 residues within 4Å: Chain B: H.78, H.112, D.113, D.223 Ligands: ZN.14 6 PLIP interactions: 4 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:H.78, B:H.112, B:D.113, B:D.223, H2O.234, H2O.351 ZN.14: 2 residues within 4Å: Chain B: D.113 Ligands: ZN.13 6 PLIP interactions: 1 interactions with chain B, 5 Ligand-Water interactions Metal complexes: B:D.113, H2O.238, H2O.297, H2O.316, H2O.321, H2O.351 ZN.25: 5 residues within 4Å: Chain C: H.78, H.112, D.113, D.223 Ligands: ZN.26 6 PLIP interactions: 4 interactions with chain C, 2 Ligand-Water interactions Metal complexes: C:H.78, C:H.112, C:D.113, C:D.223, H2O.465, H2O.582 ZN.26: 2 residues within 4Å: Chain C: D.113 Ligands: ZN.25 6 PLIP interactions: 1 interactions with chain C, 5 Ligand-Water interactions Metal complexes: C:D.113, H2O.469, H2O.528, H2O.547, H2O.552, H2O.582

24 x SO4: SULFATE ION(Non-functional Binders)

SO4.3: 6 residues within 4Å: Chain A: F.31, E.32, N.33, M.34 Chain C: R.69, R.117 Ligand excluded by PLIP SO4.4: 6 residues within 4Å: Chain A: K.56, L.154, G.156, H.157, N.158, S.161 Ligand excluded by PLIP SO4.5: 8 residues within 4Å: Chain A: V.71, P.72, R.117, G.118, F.119, A.243, E.244, A.247 Ligand excluded by PLIP SO4.6: 4 residues within 4Å: Chain A: L.96, L.205, N.206, R.211 Ligand excluded by PLIP SO4.7: 3 residues within 4Å: Chain A: Y.68, R.69, R.70 Ligand excluded by PLIP SO4.8: 5 residues within 4Å: Chain A: L.134, Y.135, S.136, T.137, Q.142 Ligand excluded by PLIP SO4.9: 5 residues within 4Å: Chain A: N.67, Q.147, S.150, I.151, L.154 Ligand excluded by PLIP SO4.10: 3 residues within 4Å: Chain A: R.45, Q.91, H.94 Ligand excluded by PLIP SO4.15: 6 residues within 4Å: Chain A: R.69, R.117 Chain B: F.31, E.32, N.33, M.34 Ligand excluded by PLIP SO4.16: 6 residues within 4Å: Chain B: K.56, L.154, G.156, H.157, N.158, S.161 Ligand excluded by PLIP SO4.17: 8 residues within 4Å: Chain B: V.71, P.72, R.117, G.118, F.119, A.243, E.244, A.247 Ligand excluded by PLIP SO4.18: 4 residues within 4Å: Chain B: L.96, L.205, N.206, R.211 Ligand excluded by PLIP SO4.19: 3 residues within 4Å: Chain B: Y.68, R.69, R.70 Ligand excluded by PLIP SO4.20: 5 residues within 4Å: Chain B: L.134, Y.135, S.136, T.137, Q.142 Ligand excluded by PLIP SO4.21: 5 residues within 4Å: Chain B: N.67, Q.147, S.150, I.151, L.154 Ligand excluded by PLIP SO4.22: 3 residues within 4Å: Chain B: R.45, Q.91, H.94 Ligand excluded by PLIP SO4.27: 6 residues within 4Å: Chain B: R.69, R.117 Chain C: F.31, E.32, N.33, M.34 Ligand excluded by PLIP SO4.28: 6 residues within 4Å: Chain C: K.56, L.154, G.156, H.157, N.158, S.161 Ligand excluded by PLIP SO4.29: 8 residues within 4Å: Chain C: V.71, P.72, R.117, G.118, F.119, A.243, E.244, A.247 Ligand excluded by PLIP SO4.30: 4 residues within 4Å: Chain C: L.96, L.205, N.206, R.211 Ligand excluded by PLIP SO4.31: 3 residues within 4Å: Chain C: Y.68, R.69, R.70 Ligand excluded by PLIP SO4.32: 5 residues within 4Å: Chain C: L.134, Y.135, S.136, T.137, Q.142 Ligand excluded by PLIP SO4.33: 5 residues within 4Å: Chain C: N.67, Q.147, S.150, I.151, L.154 Ligand excluded by PLIP SO4.34: 3 residues within 4Å: Chain C: R.45, Q.91, H.94 Ligand excluded by PLIP

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.11: 3 residues within 4Å: Chain A: S.209, H.210, R.213 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.209, A:R.213 GOL.23: 3 residues within 4Å: Chain B: S.209, H.210, R.213 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.209, B:R.213 GOL.35: 3 residues within 4Å: Chain C: S.209, H.210, R.213 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:S.209, C:R.213

3 x 15H: (1S)-1-(1-{3-[4-(1,3-BENZOTHIAZOL-2-YLAMINO)PHENOXY]PYRAZIN-2-YL}PIPERIDIN-4-YL)ETHANOL(Non-covalent)

15H.12: 17 residues within 4Å: Chain A: Y.73, H.74, D.223, L.224, S.226, V.227, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:Y.73, A:F.245, A:P.261, A:E.270, A:V.271, A:F.278 Hydrogen bonds: A:D.223, A:G.274, A:Q.275 pi-Stacking: A:F.278 15H.24: 17 residues within 4Å: Chain B: Y.73, H.74, D.223, L.224, S.226, V.227, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:Y.73, B:F.245, B:P.261, B:E.270, B:V.271, B:F.278 Hydrogen bonds: B:D.223, B:Y.242, B:G.274, B:Q.275 pi-Stacking: B:F.278 15H.36: 17 residues within 4Å: Chain C: Y.73, H.74, D.223, L.224, S.226, V.227, I.241, Y.242, F.245, P.261, M.262, K.267, E.270, V.271, G.274, Q.275, F.278 10 PLIP interactions: 10 interactions with chain C Hydrophobic interactions: C:Y.73, C:F.245, C:P.261, C:E.270, C:V.271, C:F.278 Hydrogen bonds: C:D.223, C:G.274, C:Q.275 pi-Stacking: C:F.278

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rzasa, R.M. et al., Discovery of selective biaryl ethers as PDE10A inhibitors: Improvement in potency and mitigation of Pgp-mediated efflux. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-12-12

Peptides

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A

Related Entries With Identical Sequence